Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq
Caring Brands (NASDAQ:CABR) priced an underwritten public offering of 1,000,000 common shares at $4.00 per share for gross proceeds of approximately $4,000,000, with a 45-day underwriter option to buy up to 150,000 additional shares. The offering is expected to close on November 14, 2025. The company received approval to list common shares on the Nasdaq Capital Market, with trading expected to begin on or around November 13, 2025, at which point shares will cease trading on the OTCQB. Proceeds are intended for general working capital, marketing and sales of proprietary products, and repayment of certain debt. The S-1 was declared effective on October 30, 2025.
Caring Brands (NASDAQ:CABR) ha annunciato un'offerta pubblica sottoscritta di 1.000.000 azioni ordinarie a 4,00 USD per una raccolta lorda di circa 4.000.000 USD, con una opzione di collocamento dell'underwriter valido per 45 giorni per acquistare fino a 150.000 azioni aggiuntive. L'offerta dovrebbe chiudersi il 14 novembre 2025. La società ha ottenuto l'approvazione per quotare le azioni ordinarie sul Nasdaq Capital Market, con l'inizio delle negoziazioni previsto per sul o intorno al 13 novembre 2025, a quel punto le azioni cesseranno di essere negoziate sull'OTCQB. I proventi sono destinati a capitale circolante generale, marketing e vendita di prodotti proprietari e al rimborso di alcuni debiti. L'S-1 è stato dichiarato efficace il 30 ottobre 2025.
Caring Brands (NASDAQ:CABR) fijó una oferta pública suscrita de 1.000.000 de acciones comunes a 4,00 USD por acción para ingresos brutos de aproximadamente 4.000.000 USD, con una opción de 45 días del suscriptor para comprar hasta 150,000 acciones adicionales. Se espera que la oferta cierre el 14 de noviembre de 2025. La compañía recibió la aprobación para cotizar sus acciones comunes en el Nasdaq Capital Market, con inicio de negociación previsto para el 13 de noviembre de 2025, momento en el que las acciones dejarán de cotizar en el OTCQB. Los ingresos se destinarán a capital de trabajo general, marketing y ventas de productos propietarios y al pago de ciertas deudas. El S-1 fue declarado efectivo el 30 de octubre de 2025.
Caring Brands (NASDAQ:CABR)가 주당 4.00 USD의 가격으로 100만 주의 보통주를 공모하여 약 400만 USD의 총모금액을 목표로 하며, 45일간의 청약인(언더라이더) 옵션으로 최대 추가로 15만 주를 매입할 수 있습니다. 이 공모는 2025년 11월 14일에 마감될 예정입니다. 회사는 보통주를 나스닥 칼립스 마켓에 상장 승인받았으며, 거래는 2025년 11월 13일경 시작될 것으로 예상되며, 그 시점에 OTCQB에서 거래가 중단됩니다. 수익금은 일반 운영자본, 독점 제품의 마케팅 및 판매, 그리고 특정 채무의 상환에 사용될 예정입니다. S-1은 2025년 10월 30일에 효력이 선언되었습니다.
Caring Brands (NASDAQ:CABR) a fixé une offre publique souscrite de 1 000 000 d’actions ordinaires à 4,00 USD par action pour un produit brut d'environ 4 000 000 USD, avec une option pour l'assureur de coordonnateur d'une durée de 45 jours d'achat jusqu'à 150 000 actions supplémentaires. On prévoit que l'offre se clôturera le 14 novembre 2025. La société a obtenu l'autorisation de cotation de ses actions ordinaires sur le Nasdaq Capital Market, avec un début de négociation prévu autour du 13 novembre 2025, à quel moment les actions cesseront de se négocier sur l'OTCQB. Les produits seront destinés au fonds de roulement général, au marketing et à la vente de produits propriétaires et au remboursement de certaines dettes. Le S-1 a été déclaré efficace le 30 octobre 2025.
Caring Brands (NASDAQ:CABR) hat eine unterzeichnete öffentliche Emission von 1.000.000 Stammaktien zu 4,00 USD pro Aktie aufgelegt, was Bruttoerlöse von ca. 4.000.000 USD ergibt, mit einer 45-tägigen Optionsrechte des Underwriters zum Kauf von bis zu 150.000 zusätzlichen Aktien. Die Emission soll voraussichtlich am 14. November 2025 abgeschlossen werden. Das Unternehmen hat die Genehmigung erhalten, seine Stammaktien an der Nasdaq Capital Market zu notieren; der Handel soll um den 13. November 2025 herum beginnen, zu dem Zeitpunkt werden die Aktien im OTCQB außer Handel sein. Die Erlöse sollen für allgemeines Working Capital, Marketing und Vertrieb von eigentümergeführten Produkten sowie zur Rückzahlung einiger Schulden verwendet werden. Die S-1 wurde am 30. Oktober 2025 für wirksam erklärt.
Caring Brands (NASDAQ:CABR) حدّدت عرضاً عاماً مضمونا بـ 1,000,000 سهماً عادياً بسعر 4.00 دولار للسهم لإيرادات إجمالية تقدّر بـ 4,000,000 دولار, مع خيار من المكتتب يستمر 45 يوماً لشراء حتى 150,000 سهماً إضافياً. من المتوقع إغلاق العرض في 14 نوفمبر 2025. تلقت الشركة موافقة لإدراج الأسهم العادية في سوق ناسداك كابيتال، مع توقع بدء التداول في أو حول 13 نوفمبر 2025، وعندها ستتوقف الأسهم عن التداول في OTCQB. سيتم توجيه العائدات إلى رأس المال العامل العام والتسويق والمبيعات للمنتجات الملكية وسداد بعض الديون. تم إعلان فاعلية نموذج S-1 في 30 أكتوبر 2025.
- Priced $4.0M offering: 1,000,000 shares at $4.00
- Nasdaq Capital Markets listing approved; trading around Nov 13, 2025
- 45-day option for 150,000 additional shares granted to underwriters
- Proceeds allocated to marketing, sales, working capital, and debt repayment
- Immediate dilution from 1,000,000 new shares issued
- Up to 15% additional dilution if 150,000 option shares exercised
- Proceeds partly allocated to debt repayment rather than growth investments
Insights
Uplisting and a concurrent $4.0M underwritten offering provide clear near‑term financing and a Nasdaq listing transition.
Caring Brands priced an underwritten U.S. public offering of 1,000,000 common shares at
This transaction supplies immediate liquidity and formal market access via Nasdaq, and the disclosed uses include marketing, sales, general working capital and repayment of certain debt. The business effect depends directly on the net proceeds after underwriting discounts and expenses and on execution of the stated uses; no performance or operational metrics are provided here, so impact should be judged on funding size and listing status alone. Watch for the final prospectus filing, the actual net proceeds figure after fees, and the exercise (or not) of the underwriter option within the 45-day window as near-term milestones that will clarify capital available and dilution.
FORT PIERCE, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the pricing of its underwritten U.S. public offering of 1,000,000 common shares at a public offering price of
In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 150,000 common shares at the public offering price, less the underwriting discounts and commissions. The Offering is expected to close on November 14, 2025, subject to customary closing conditions.
In connection with the Offering, Caring Brands has received approval to list its common shares on the Nasdaq Capital Markets, with the shares expected to begin trading on or around the date of November 13, 2025 under the symbol “CABR”, at which point our common stock will cease to be traded on the OTCQB.
Caring Brands intends to use the net proceeds received from this offering for general and working capital purposes, including but not limited to marketing and sales of its proprietary products, and for the repayment of certain debt.
D. Boral Capital LLC (“D. Boral”) is acting as the sole underwriter in connection with this offering.
A registration statement on Form S-1 relating to the Offering, as amended, was filed with the Securities and Exchange Commission (the “SEC”) (File Number: 333-289767) and was automatically declared effective on October 30, 2025. The Offering is being made only by means of a prospectus. A copy of the final prospectus will be filed with the SEC, which may be obtained, when available, from D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022 by email to info@dboralcapital.com, or by calling (212) 970-5150.
Before you invest, you should read the registration statement, the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, nor shall there be any offer, solicitation or sale of such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About Caring Brands, Inc.
Caring Brands is a wellness consumer products company who offers several over-the-counter (OTC) and cosmetic consumer products. The Company’s product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, and a jellyfish sting protective suncare line catering to diverse health and wellness needs. The Company’s method of operation ensures that the mechanism of action of all products is established, efficacy is determined through controlled clinical trials, products are protected by issued and filed patents, and products have acceptable commercial stability.
Forward-Looking Statement
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company’s proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the proposed Offering will be successfully completed. Investors can find many (but not all) of these statements by the use of words such as “believe”, “plan”, “expect”, “intend”, “should”, “seek”, “estimate”, “will”, “aim” and “anticipate” or other similar expressions in the prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov.
For further information, please contact:
Brian S John
(561) 896-7616